Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

System Delay and Clinical Outcome Among Chinese Patients With AMI Treated With Reperfusion Therapy (MOODY Study)

NCT03051048 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.

NCT NCT03051048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03051048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
System Delay and Clinical Outcome Among Chinese Patients With AMI Treated With Reperfusion Therapy (MOODY Study)
Lead sponsor
Nanjing First Hospital, Nanjing Medical University
Phase
Observational
Overall status
Completed
Start date
January 1, 1999
Completion date
September 30, 2017
Enrollment
8,000 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease